The team at Drug Discovery Today are delighted to present the new Podcast section for the website. We hope, over the coming months, to cover issues of the utmost importance and interest to drug discovery professionals. The topics will encompass every aspect of drug discovery, including discussions on the discovery environment, pipeline issues, new technologies, ethical issues and regulatory aspects, amongst others.
We will feature some of the biggest names in Science and Technology and hope to provide interviews that are thought-provoking and informative. As always, with Drug Discovery Today, we believe that you, the reader (and listener), should have a strong say in its content. So if you have a suggestion for a topic that you think we should cover, please e-mail me with your thoughts at s.carney@elsevier.com
Dr. Christopher Lipinski
Dr. Christopher Lipinski has been one of the most influential scientists in the Pharmaceutical industry in recent history. He held the post of Adjunct Senior Research Fellow at the Pfizer Global R&D from June 2002. He now acts as a Scientific Advisor to Melior Discovery, a company specializing in drug repurposing. He has held many positions in august scientific societies including membership of the American Chemical Society (ACS), the American Association of Pharmaceutical Sciences (AAPS), and the Society of Biomolecular Sciences (SBS) to name but a few. He is on the Editorial board of a number of journals, not least Drug Discovery Today. Perhaps most famous as the developer of the "rule of five" – a series of rules established to screen compounds for the likelihood that they will have acceptable oral absorption characteristics. Chris has received many honours, most notably the 2006 Society for Biomolecular Sciences Achievement Award winner and the 2005 E. B. Hershberg Award for Important Discoveries in Medicinally Active Substances from the ACS.
About the Dr. Stephen Minger Podcast
This podcast features Dr. Stephen Minger, one of the World’s leading lights in Stem Cell biology. Dr. Minger has been in the news recently as he has received one of only two licenses awarded in the UK allowing his team to produce hybrid embryos. Dr. Minger received a BA in Psychology and a PhD in Pathology (Neurosciences) from the University of Minnesota. While a post-doctoral fellow in the laboratory of Professor Fred Gage, Dr. Minger began his research in neural stem cell biology. More recently, Dr. Minger and his research group has investigated a wide range of somatic stem cell populations, as well as mouse and human embryonic stem (hES) cells. In 2002, with Dr Susan Pickering and Professor Peter Braude, he was awarded one of the first two licenses granted by the Human Fertilisation and Embryology Authority for the derivation of human ES cells. The Minger group generated the first hES cell line in the UK and was one of the first groups to deposit such a line into the UK Stem Cell Bank.
Stay up to date with the latest
developments in drug discovery by signing up for our
monthly Editor's
Choice e-newsletter
Drug Discovery Today Podcasts
